Po‐Hung Lin
Papers
1
Total Citations
4
H-Index
1
About
Po-Hung Lin is a leading urological oncologist whose research focuses on the surgical management of upper tract urothelial carcinoma (UTUC), a disease with particularly high prevalence in Taiwan. His major contributions center on evaluating the efficacy of segmental ureterectomy (SU) as a nephron-sparing alternative to radical nephroureterectomy for selected patients with mid- and distal ureteral tumors. In his landmark 2024 nationwide collaborative study—which has already garnered 4 citations—Lin analyzed treatment outcomes across Taiwan, providing critical evidence that SU offers comparable oncological control while preserving renal function in a high-endemic region. This work directly addresses gaps in National Comprehensive Cancer Network guidelines by offering region-specific data from a UTUC hotspot. Lin’s research has significant clinical impact, helping to refine surgical decision-making and reduce overtreatment in endemic areas. His collaborative approach, uniting multiple Taiwanese medical centers, underscores his commitment to generating robust, real-world evidence that bridges international guidelines with local disease patterns. For students and researchers, Lin’s work exemplifies how targeted epidemiological studies can transform standard-of-care practices in resource-limited, high-burden settings.
Research Focus
Key Achievements
Top Papers
- 1